Patent details

Basic Information

Publication number:

EP1497266

PCT Application Number:

PCT/EP/2003/003197

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037148897

PCT Publication Number:

WO/2003/080580

First applicant's nationality:

Switzerland (CH)

Translation Language:

EPO Publication Language:

English

English Title of Invention:

QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS

French Title of Invention:

DERIVES DE QUINOLEINE ET LEUR UTILISATION COMME LIGANDS 5-HT6

German Title of Invention:

CHINOLINDERIVATE UND DEREN VERWENDUNG ALS 5-HT6 LIGANDEN

SPC Number:

Dates

Filing date:

25/03/2003

Grant date:

11/06/2008

EP Publication Date:

11/06/2008

PCT Publication Date:

02/10/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/01/2005

EP B1 Publication Date:

11/06/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/03/2020

Expiration date:

25/03/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/03/2017

 

 

Name:

Axovant Sciences GmbH

Address:

c/o Vischer AG , Aeschenvorstadt 4, 4010, BASEL, Switzerland (CH)

History of Owners

From:

03/08/2015

To:

08/03/2017

Name:

AXOVANT SCIENCES LTD.

Address:

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON, BERMUDA HM11, Bermuda (BM)

From:

03/08/2015

To:

03/08/2015

Name:

ROIVANT NEUROSCIENCES LTD.

Address:

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON , BERMUDA HM11, Bermuda (BM)

From:

25/03/2003

To:

02/08/2015

Name:

GLAXO GROUP LIMITED

Address:

Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 ONN, United Kingdom (GB)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

20/08/2008

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

JOHNSON Christopher, Norbert, GlaxoSmithKline

Address:

United Kingdom (GB)

2

Name:

AHMED Mahmood, GlaxoSmithKline

Address:

United Kingdom (GB)

3

Name:

WITTY David, GlaxoSmithKline

Address:

United Kingdom (GB)

4

Name:

JONES Martin, C, GlaxoSmithKline

Address:

United Kingdom (GB)

5

Name:

WADE Charles, Edward, GlaxoSmithKline

Address:

United Kingdom (GB)

6

Name:

MACDONALD Gregor, James, GlaxoSmithKline

Address:

United Kingdom (GB)

7

Name:

THOMPSON Mervyn, GlaxoSmithKline

Address:

United Kingdom (GB)

8

Name:

MOSS Stephen, Frederick, GlaxoSmithKline

Address:

United Kingdom (GB)

Priority

1

Priority Number:

0207289

Priority Date:

27/03/2002

Priority Country:

United Kingdom (GB)

2

Priority Number:

0225678

Priority Date:

04/11/2002

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 215/40;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2017/02

Publication date:

22/06/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20170000049A

Date Registered:

08/03/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Axovant Sciences GmbH

Address:

c/o Vischer AG , Aeschenvorstadt 4, 4010, BASEL, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/03/2019

Last Annual Fee Paid Number:

17

Last Annual Fee Paid Amount:

246 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
08/03/2017	Request For Change	1
08/03/2017	General Document	12